|
|
||||||||
Articles |
Synthetic glucocorticoids have become an important clinical tool with which to advance fetal lung maturation in women at risk of early preterm birth, and this has succeeded in reducing neonatal mortality and morbidity from respiratory distress syndrome. Although previous studies have shown that glucocorticoids have deleterious consequences on fetal development, there is little information regarding the effects of clinically relevant repeated maternal doses of glucocorticoids on fetal growth and hypothalamic-pituitary-adrenal (HPA) function. We hypothesised that repeated prenatal exposure to increased concentrations of glucocorticoids would alter fetal growth and HPA axis development. Pregnant ewes were injected with betamethasone (0.5 mg/kg) or vehicle at 104, 111 and 118 days of gestation (term 150 days). Animals were sacrificed at 125 and 146 days of gestation, at which time fetal weights were recorded. Maternal and fetal blood samples were gathered and fetal tissue collected. Maternal oestradiol concentrations were significantly greater than those in controls at 125 days of gestation, but were not different at 146 days. Maternal plasma progesterone concentrations were similar between groups at both 125 and 146 days of gestation. Weight at birth was significantly reduced by 23% at 125 days and 19% at 146 days of gestation (P<0.05) after exposure to glucocorticoid. Cord plasma ACTH concentrations were not significantly different between groups at day 125, but were significantly increased in day 146 fetuses of ewes that had received betamethasone (P<0.05). Cord plasma cortisol concentrations followed the same trend, although differences were not statistically significant. Cord plasma corticosteroid binding capacity (CBC) was significantly increased at 125 days of gestation in fetuses of betamethasone-treated animals (P<0.05), but not at 146 days of gestation. To examine the mechanisms regulating the increase in cord plasma ACTH of 146-day fetuses, we used in situ hybridisation to determine the distribution and levels of mRNA encoding key pituitary and hypothalamic neuropeptides of the HPA axis. In pituitaries of 146-day fetuses, there were no significant differences in the regional pattern of distribution or amounts of pro-opiomelanocortin (POMC) mRNA between betamethasone-treated animals and controls, in either the pars intermedia or the inferior and superior regions of the pars distalis. Neither prohormone convertase (PC)-1 nor PC-2 mRNA levels in pituitaries of 146-day fetuses were significantly different between treatment groups. After maternal betamethasone, immunoreactive ACTH peptide content in the fetal pars distalis was not different but glucocorticoid receptor (GR) mRNA levels in the pars distalis were increased significantly (P<0.05). No significant difference in distribution pattern or concentrations of corticotrophin-releasing hormone (CRH) mRNA, GR mRNA, oxytocin mRNA and pre-proenkephalin mRNA were found in hypothalami from fetuses at 146 days of gestation after betamethasone treatment. We conclude that antenatal betamethasone given to pregnant sheep in a manner similar to that used in human obstetric practice results in reduced weight at birth at 125 and 146 days, and altered basal cord levels of plasma ACTH and corticosteroid binding capacity, but these changes are not reflective of changes in steady state concentrations of POMC and CRH mRNA in the fetal pituitary or hypothalamus.
This article has been cited by other articles:
![]() |
G. Belteki and G. C S Smith Single versus multiple antenatal steroids in threatened preterm delivery: more benefit or harm? Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2009; 94(1): 5 - 7. [Full Text] [PDF] |
||||
![]() |
K. L. Gatford, J. A. Owens, S. Li, T. J. M. Moss, J. P. Newnham, J. R. G. Challis, and D. M. Sloboda Repeated betamethasone treatment of pregnant sheep programs persistent reductions in circulating IGF-I and IGF-binding proteins in progeny Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E170 - E178. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M Sloboda, T. J M Moss, S. Li, S. G Matthews, J. R G Challis, and J. P Newnham Expression of glucocorticoid receptor, mineralocorticoid receptor, and 11{beta}-hydroxysteroid dehydrogenase 1 and 2 in the fetal and postnatal ovine hippocampus: ontogeny and effects of prenatal glucocorticoid exposure J. Endocrinol., May 1, 2008; 197(2): 213 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Lam, S. Sharma, R. S. Baker, J. Hilshorst, J. Lombardi, K. E. Clark, and P. Eghtesady Fetal stress response to fetal cardiac surgery. Ann. Thorac. Surg., May 1, 2008; 85(5): 1719 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Braun, S. Li, T. J M Moss, J. P Newnham, J. R G Challis, P. D Gluckman, and D. M Sloboda Maternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep J. Endocrinol., August 1, 2007; 194(2): 337 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hauser, A. Dettling-Artho, S. Pilloud, C. Maier, A. Knapman, J. Feldon, and C. R. Pryce Effects of Prenatal Dexamethasone Treatment on Postnatal Physical, Endocrine, and Social Development in the Common Marmoset Monkey Endocrinology, April 1, 2007; 148(4): 1813 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J McNeil, M. O Nwagwu, A. M Finch, K. R Page, A. Thain, H. J McArdle, and C. J Ashworth Glucocorticoid exposure and tissue gene expression of 11{beta} HSD-1, 11{beta} HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth Reproduction, March 1, 2007; 133(3): 653 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Sloboda, T. J. M. Moss, S. Li, D. Doherty, I. Nitsos, J. R. G. Challis, and J. P. Newnham Prenatal betamethasone exposure results in pituitary-adrenal hyporesponsiveness in adult sheep Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E61 - E70. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Reini, C. E. Wood, E. Jensen, and M. Keller-Wood Increased maternal cortisol in late-gestation ewes decreases fetal cardiac expression of 11beta-HSD2 mRNA and the ratio of AT1 to AT2 receptor mRNA Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1708 - R1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gray, B. S Stonestreet, S. Thamotharan, G. B Sadowska, M. Daood, J. Watchko, and S. U Devaskar Skeletal muscle glucose transporter protein responses to antenatal glucocorticoids in the ovine fetus. J. Endocrinol., May 1, 2006; 189(2): 219 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Sadowska, C. S. Patlak, K. H. Petersson, and B. S. Stonestreet Effects of Multiple Courses of Antenatal Corticosteroids on Blood-Brain Barrier Permeability in the Ovine Fetus Reproductive Sciences, May 1, 2006; 13(4): 248 - 255. [Abstract] [PDF] |
||||
![]() |
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Jaquiery, M. H. Oliver, F. H. Bloomfield, K. L. Connor, J. R. G. Challis, and J. E. Harding Fetal exposure to excess glucocorticoid is unlikely to explain the effects of periconceptional undernutrition in sheep J. Physiol., April 1, 2006; 572(1): 109 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. J. Pua, B. S. Stonestreet, A. Cullen, A. Shahsafaei, G. B. Sadowska, and M. E. Sunday Histochemical Analyses of Altered Fetal Lung Development Following Single vs Multiple Courses of Antenatal Steroids J. Histochem. Cytochem., December 1, 2005; 53(12): 1469 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Sloboda, T. J. M. Moss, S. Li, D. A. Doherty, I. Nitsos, J. R. G. Challis, and J. P. Newnham Hepatic glucose regulation and metabolism in adult sheep: effects of prenatal betamethasone Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E721 - E728. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chisaka, J. F. Johnstone, M. Premyslova, Z. Manduch, and J. R.G. Challis Effect of Pro-inflammatory Cytokines on Expression and Activity of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Cultured Human Term Placental Trophoblast and Human Choriocarcinoma JEG-3 Cells Reproductive Sciences, July 1, 2005; 12(5): 303 - 309. [Abstract] [PDF] |
||||
![]() |
E. Jensen, C. E. Wood, and M. Keller-Wood Chronic alterations in ovine maternal corticosteroid levels influence uterine blood flow and placental and fetal growth Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R54 - R61. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. van Beek, H. Guan, L. Julan, and K. Yang Glucocorticoids Stimulate the Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Cultured Human Placental Trophoblast Cells J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5614 - 5621. [Abstract] [Full Text] [PDF] |
||||
![]() |
A L Fowden and A J Forhead Endocrine mechanisms of intrauterine programming Reproduction, May 1, 2004; 127(5): 515 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Stonestreet, S. Watkins, K. H. Petersson, and G. B. Sadowska Effects of Multiple Courses of Antenatal Corticosteroids on Regional Brain and Somatic Tissue Water Content in Ovine Fetuses Reproductive Sciences, April 1, 2004; 11(3): 166 - 174. [Abstract] [PDF] |
||||
![]() |
M. A. Kutzler, E. K Ruane, T. Coksaygan, S. E. Vincent, and P. W. Nathanielsz Effects of Three Courses of Maternally Administered Dexamethasone at 0.7, 0.75, and 0.8 of Gestation on Prenatal and Postnatal Growth in Sheep Pediatrics, February 1, 2004; 113(2): 313 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. W. Fletcher, X. H. Ma, W. X. Wu, P. W. Nathanielsz, H. H. G. McGarrigle, A. L. Fowden, and D. A. Giussani Antenatal glucocorticoids reset the level of baseline and hypoxemia-induced pituitary-adrenal activity in the sheep fetus during late gestation Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E311 - E319. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Bloomfield, M. H. Oliver, C. D. Giannoulias, P. D. Gluckman, J. E. Harding, and J. R. G. Challis Brief Undernutrition in Late-Gestation Sheep Programs the Hypothalamic-Pituitary-Adrenal Axis in Adult Offspring Endocrinology, July 1, 2003; 144(7): 2933 - 2940. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jensen, C. Wood, and M. Keller-Wood The Normal Increase in Adrenal Secretion During Pregnancy Contributes to Maternal Volume Expansion and Fetal Homeostasis Reproductive Sciences, November 1, 2002; 9(6): 362 - 371. [Abstract] [PDF] |
||||
![]() |
V. E. Murphy, T. Zakar, R. Smith, W. B. Giles, P. G. Gibson, and V. L. Clifton Reduced 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Activity Is Associated with Decreased Birth Weight Centile in Pregnancies Complicated by Asthma J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1660 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dodic, A. Peers, K. Moritz, V. Hantzis, and E. M. Wintour No evidence for HPA reset in adult sheep with high blood pressure due to short prenatal exposure to dexamethasone Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R343 - R350. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. M. Moss, D. M. Sloboda, L. C. Gurrin, R. Harding, J. R. G. Challis, and J. P. Newnham Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R960 - R970. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Green Programming of Endocrine Mechanisms of Cardiovascular Control and Growth Reproductive Sciences, April 1, 2001; 8(2): 57 - 68. [Abstract] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |